01-17-2018 12:02 PM CET - Health & Medicine

Clinical Analysis Report 2017: Cholesterol Testing Market Is Anticipated To Reach USD 10,290.57 Million By 2025

Press release from: Data Bridge Market Research
Global Cholesterol Testing Market Trend 2024
Global Cholesterol Testing Market Trend 2024

Global Cholesterol Testing Market is projected to reach USD 10,290.57 million by 2025 from USD 5,727.60 million in 2018, at a CAGR of 7.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Click Here for Free Sample Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Global Cholesterol Testing Market: Segmentation

Global Cholesterol Testing Market By Product Type (Test Kits, Testing Strips), By Test (Lipid Panel Test/Complete Lipid Profile {Total Cholesterol Test, HDL Cholesterol Test, LDL Cholesterol Test, Triglycerides/VLDL Cholesterol Test}, By Test Type (Non-Invasive, Invasive), By Prescription Mode (Over The Counter, Prescription Based), By End-Users (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)

Drivers: Global Cholesterol Testing Market

The major factors driving the growth of this market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare and increasing cholesterol home/self-testing market are boosting the growth of the global cholesterol testing market.

Cholesterol testing is the method which is used for diagnosis of the cholesterol level in the body. Much technological advancement had taken place in the cholesterol testing procedures as there had been innovative technologies. Some of the example for technological advancements is mentioned below.
• In July 2016, Alere entered into a partnership with healthcare technology company BioIQ for providing interface between BioIQ’s software platform, SoftSuite Dx and the Alere Cholestech LDX System for the point of care lipid profile and glucose results for employee biometric screening events.
• In November 2014, Roche Diagnostics Ltd. received FDA Clearance for Strep A Test on cobasLiat System, the first molecular point of care test.
The new technologies are emerging in the market that is helpful for the non-invasive techniques of cholesterol testing. This will enhance the growth of the cholesterol testing market.

Purchase Full Report of Global Cholesterol Testing Market @ databridgemarketresearch.com/press-release/global-cholest...


Cardiovascular diseases (CVDs) are the disorders that affect the heart and blood vessels and it comprises of cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. The individuals with cardiovascular diseases are at a higher risk of some common problems such as glucose, blood pressure and lipids, overweight and obesity. The risen cholesterol levels are one of the major factors in the rise of heart diseases. Some of the statistics for cardiovascular disease and obesity is mentioned below:
• According to Centers for Disease Control and Prevention (CDC), approximately 610,000 people die due to heart disease in the U.S. per year.
• According to European Heart Network, every year cardiovascular disease leads to 3.9 million deaths in Europe and around 1.8 million deaths in the European Union.
• According to American Heart Association, in the U.S. more than one-third (approximately 35.0%) of adults are obese (over 78 million adults).
• According to Heart Foundation, in 2011, the prevalence of high cholesterol increases in the age of 55 to 64 years, and half of the population among them have high total cholesterol level.
Rising number of obesity and cardiovascular diseases leads to high blood cholesterol and triglyceride levels which increase the cholesterol testing requirement leading to growth of the market.

Global Cholesterol Testing Market: Major Players

Some Of the Major Players Operating in this Market are:-
• Abbott Laboratories,
• Accutech,
• LLC,
• Beckman Coulter Inc.,
• Bio-Rad Laboratories Inc.,
• Prima Lab SA,
• Quest Diagnostics Inc.,
• Home Access Health Corporation,
• Hoffmann-La Roche AG,
• Siemens AG, and
• Sigma-Aldrich Corp.
• Among others.

Request for Detail Report Enquire Click Here @: databridgemarketresearch.com/inquire-before-buying/?dbmr=...

Related Report

Global Point-Of-Care Diagnostics Market – Industry Trends and Forecast to 2024

Global Point-Of-Care Diagnostics Market By Disease (Diabetes, Cardiac, Coagulation, Cholesterol, Urinary, Blood Gas, Drug Of Abuse, Infectious, Pregnancy & Fertility, Cancer, Hematology, Others), By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-point-of-care...

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.
News-ID: 904622 • Views: 340
More releasesMore releases

You can edit or delete your press release here: